Indegene’s IPO will hit the market on April 06, 2024, and closes on April 08, 2024. The Indegene IPO GMP Kostak rate and subject to sauda updated as of today. The Indegene IPO Grey Market Premium has started with high premium rates at this time, we need to wait for the rates to change with the market sentiment in a few days or to stabilize the rates. You can check the Indegene IPO subscription status here.
Indegene Limited provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. The company has established client relationships with each of the 20 largest biopharmaceutical companies in the world.
Indegene IPO Issue size of ₹1841.76 Crores, in which Fresh Issue of ₹760.00 Crores and Offer For Sale of ₹1081.76 Crores and issue price band has been fixed at ₹430 to ₹452 Per Share. The Indegene IPO is to be listed on May 13, 2024, on NSE and BSE.
What is Indegene IPO GMP Today?
■ The Indegene IPO GMP Today Or Grey Market Premium is ₹252-₹255.
What is Indegene IPO Kostak Rates Today?
■ The Indegene IPO Kostak rate is ₹0.
What is Indegene IPO Subject to Sauda Price Today?
■ The Indegene IPO Subject to Sauda rates is ₹6400.
Indegene IPO Approximately Returns?
■ The Indegene IPO’s approximate return is 45%-50%, and it can also change according to the Market Sentiment.
Indegene IPO GMP Live, Kostak, & Subject :
| Date | GMP | Kostak | Subject |
| 08 May 2024 | ₹252-₹255  | ₹0 | ₹6400 |
| 07 May 2024 | ₹252-₹255 | ₹0 | ₹6400 |
| 06 May 2024 | ₹252-₹255  | ₹0 | ₹6400 |
| 05 May 2024 | ₹262-₹265 | ₹0 | ₹6700 |
| 04 May 2024 | ₹262-₹265  | ₹0 | ₹6700 |
| 03 May 2024 | ₹242-₹245 | ₹0 | ₹6000 |
| 02 May 2024 | ₹240-₹245 | ₹0 | ₹6000 |
| 01 May 2024 | ₹240-₹245 | ₹0 | ₹6000 |
| 30 Apr 2024 | ₹220-₹225 | ₹0 | ₹5600 |
| 29 Apr 2024 | ₹168-₹170 | ₹0 | ₹4200 |
| 28 Apr 2024 | ₹168-₹170 | ₹0 | ₹4200 |
| 27 Apr 2024 | ₹168-₹170 | ₹0 | ₹4200 |
IPO GMP Facts :
- The GMP is usually higher for IPOs of well-known companies with strong fundamentals.
- The GMP is also likely to be higher for IPOs that are heavily subscribed.
- It is important to do your own research before investing in an IPO, regardless of the GMP.
- The IPO GMP is estimated, considering market volatility, limited historical data, underwriting conditions, legal risks, and potential dilution.
IPO GMP Disclaimer :
- GMP is not an indicator of the final listing price: The GMP is just a reflection of the demand and supply of the IPO shares in the grey market. The final listing price will depend on a number of factors, including the overall market sentiment and the performance of the company in the post-IPO period.
- The GMP can be volatile: The GMP can fluctuate significantly in the days leading up to the IPO listing. This is due to the uncertainty surrounding the final listing price and the volatility of the stock market in general.
- There is no guarantee of profit: Even if the GMP is high, there is no guarantee that the IPO shares will list at a profit. The final listing price could be lower than the GMP, or the shares could even decline in value after listing.
- Investing in IPOs carries risks: IPOs are considered to be high-risk investments. There is always the possibility that the company could fail, or that the shares could be diluted in the future.
- Risk Factors: Identify and articulate the key risk factors that could impact the IPO GMP and subsequent trading of the company’s shares. These may include industry-specific risks, regulatory uncertainties, economic downturns, and competitive pressures.
| Indegene IPO Details: Click Here Indegene IPO Subscription: Click Here Indegene IPO Allotment: Click Here Indegene IPO Listing: Click Here |
All Indegene IPO-related links are available here. If you want to know the details then click on the click here Link.
Disclaimer: STOCK MARKET INVESTMENTS ARE SUBJECT TO MARKET RISKS, READ ALL SCHEME-RELATED DOCUMENTS CAREFULLY BEFORE INVESTING.